Intercept Pharmaceuticals, Inc. EBITDA Margin 2013-2023 | ICPT

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Intercept Pharmaceuticals, Inc. (ICPT) over the last 10 years. The current EBITDA margin for Intercept Pharmaceuticals, Inc. as of September 30, 2023 is .
EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2023-09-30 $0.32B $-0.07B -21.07%
2023-06-30 $0.31B $-0.07B -23.13%
2023-03-31 $0.30B $-0.07B -25.08%
2022-12-31 $0.29B $-0.07B -22.73%
2022-09-30 $0.25B $-0.07B -28.85%
2022-06-30 $0.24B $-0.07B -29.75%
2022-03-31 $0.24B $-0.06B -26.89%
2021-12-31 $0.26B $-0.06B -22.99%
2021-09-30 $0.22B $-0.06B -28.38%
2021-06-30 $0.24B $-0.10B -42.55%
2021-03-31 $0.24B $-0.14B -56.97%
2020-12-31 $0.24B $-0.19B -82.55%
2020-09-30 $0.30B $-0.25B -81.13%
2020-06-30 $0.28B $-0.27B -94.01%
2020-03-31 $0.27B $-0.28B -102.93%
2019-12-31 $0.25B $-0.29B -113.10%
2019-09-30 $0.23B $-0.28B -120.60%
2019-06-30 $0.22B $-0.27B -122.02%
2019-03-31 $0.20B $-0.27B -139.80%
2018-12-31 $0.18B $-0.27B -147.22%
2018-09-30 $0.17B $-0.29B -173.94%
2018-06-30 $0.16B $-0.29B -184.91%
2018-03-31 $0.15B $-0.30B -208.22%
2017-12-31 $0.13B $-0.31B -238.93%
2017-09-30 $0.11B $-0.32B -300.93%
2017-06-30 $0.07B $-0.34B -478.87%
2017-03-31 $0.05B $-0.34B -741.30%
2016-12-31 $0.03B $-0.39B -1548.00%
2016-09-30 $0.01B $-0.37B -3318.18%
2016-06-30 $0.01B $-0.34B -5600.00%
2016-03-31 $0.00B $-0.31B inf%
2015-12-31 $0.00B $-0.22B -22100.00%
2015-09-30 $0.00B $-0.17B -16900.00%
2015-06-30 $0.00B $-0.16B -15500.00%
2015-03-31 $0.00B $-0.13B -13000.00%
2014-12-31 $0.00B $-0.11B inf%
2014-09-30 $0.00B $-0.09B inf%
2014-06-30 $0.00B $-0.07B inf%
2014-03-31 $0.00B $-0.05B inf%
2013-12-31 $0.00B $-0.04B inf%
2013-09-30 $0.00B $-0.03B inf%
2013-06-30 $0.00B $-0.02B -2400.00%
2013-03-31 $0.00B $-0.02B -1100.00%
2012-12-31 $0.00B $-0.02B -600.00%